These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

205 related items for PubMed ID: 23998972

  • 21. The prevalence of and risk factors for erosive oesophagitis and non-erosive reflux disease: a nationwide multicentre prospective study in Korea.
    Kim N, Lee SW, Cho SI, Park CG, Yang CH, Kim HS, Rew JS, Moon JS, Kim S, Park SH, Jung HC, Chung IS, H. pylori and Gerd Study Group of Korean College of Helicobacter and Upper Gastrointestinal Research.
    Aliment Pharmacol Ther; 2008 Jan 15; 27(2):173-85. PubMed ID: 17973646
    [Abstract] [Full Text] [Related]

  • 22. Gastro-oesophageal reflux disease and Helicobacter pylori or gastro-oesophageal reflux disease from Helicobacter pylori?
    Lundell L.
    Eur J Gastroenterol Hepatol; 2001 May 15; 13 Suppl 1():S23-7. PubMed ID: 11430505
    [Abstract] [Full Text] [Related]

  • 23. Epidemiology of reflux disease and CLE in East Asia.
    Hongo M, Shoji T.
    J Gastroenterol; 2003 Mar 15; 38 Suppl 15():25-30. PubMed ID: 12698867
    [Abstract] [Full Text] [Related]

  • 24. A qualitative synthesis of gastro-oesophageal reflux in bronchiectasis: Current understanding and future risk.
    McDonnell MJ, O'Toole D, Ward C, Pearson JP, Lordan JL, De Soyza A, Loebinger M, Chalmers JD, Laffey JG, Rutherford RM.
    Respir Med; 2018 Aug 15; 141():132-143. PubMed ID: 30053958
    [Abstract] [Full Text] [Related]

  • 25. Environmental - lifestyle related factors.
    Roman S, Pandolfino JE.
    Best Pract Res Clin Gastroenterol; 2010 Dec 15; 24(6):847-59. PubMed ID: 21126698
    [Abstract] [Full Text] [Related]

  • 26. Epidemiology and natural history of reflux disease.
    Nandurkar S, Talley NJ.
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Oct 15; 14(5):743-57. PubMed ID: 11003807
    [Abstract] [Full Text] [Related]

  • 27. Review article: Helicobacter pylori and gastro-oesophageal reflux disease.
    Delaney B, McColl K.
    Aliment Pharmacol Ther; 2005 Aug 15; 22 Suppl 1():32-40. PubMed ID: 16042657
    [Abstract] [Full Text] [Related]

  • 28. High prevalence of gastroesophageal reflux symptoms and esophagitis with or without symptoms in the general adult Swedish population: a Kalixanda study report.
    Ronkainen J, Aro P, Storskrubb T, Johansson SE, Lind T, Bolling-Sternevald E, Graffner H, Vieth M, Stolte M, Engstrand L, Talley NJ, Agréus L.
    Scand J Gastroenterol; 2005 Mar 15; 40(3):275-85. PubMed ID: 15932168
    [Abstract] [Full Text] [Related]

  • 29. [Prevalence of Helicobacter pylori infection among children and youth with acid gastroesophageal reflux].
    Brazowski J, Nowak A, Szaflarska-Popławska A.
    Przegl Lek; 2006 Mar 15; 63(3):128-30. PubMed ID: 16967700
    [Abstract] [Full Text] [Related]

  • 30. Helicobacter pylori infection influences symptomatic response to anti-secretory therapy in patients with GORD--crossover comparative study with famotidine and low-dose lansoprazole.
    Adachi K, Hashimoto T, Komazawa Y, Mihara T, Furuta K, Fujishiro H, Ishihara S, Amano Y, Hattori S, Kinoshita Y.
    Dig Liver Dis; 2005 Jul 15; 37(7):485-90. PubMed ID: 15975534
    [Abstract] [Full Text] [Related]

  • 31. Dietary intake and the risk of gastro-oesophageal reflux disease: a cross sectional study in volunteers.
    El-Serag HB, Satia JA, Rabeneck L.
    Gut; 2005 Jan 15; 54(1):11-7. PubMed ID: 15591498
    [Abstract] [Full Text] [Related]

  • 32. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease.
    Xie T, Cui X, Zheng H, Chen D, He L, Jiang B.
    Eur J Gastroenterol Hepatol; 2013 Oct 15; 25(10):1195-205. PubMed ID: 23839160
    [Abstract] [Full Text] [Related]

  • 33. Famotidine vs. omeprazole: a prospective randomized multicentre trial to determine efficacy in non-erosive gastro-oesophageal reflux disease.
    Fujiwara Y, Higuchi K, Nebiki H, Chono S, Uno H, Kitada K, Satoh H, Nakagawa K, Kobayashi K, Tominaga K, Watanabe T, Oshitani N, Arakawa T.
    Aliment Pharmacol Ther; 2005 Jun 15; 21 Suppl 2():10-8. PubMed ID: 15943841
    [Abstract] [Full Text] [Related]

  • 34. Prevalence of oesophagitis in patients with persistent upper respiratory symptoms.
    Catalano F, Terminella C, Grillo C, Biondi S, Zappalà M, Bentivegna C.
    J Laryngol Otol; 2004 Nov 15; 118(11):857-61. PubMed ID: 15638971
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Patterns of gastritis and the effect of eradicating Helicobacter pylori on gastro-oesophageal reflux disease in Western patients with non-ulcer dyspepsia.
    Vakil N, Talley NJ, Stolte M, Sundin M, Junghard O, Bolling-Sternevald E.
    Aliment Pharmacol Ther; 2006 Jul 01; 24(1):55-63. PubMed ID: 16803603
    [Abstract] [Full Text] [Related]

  • 39. Systematic review: the effect of Helicobacter pylori and its eradication on gastro-oesophageal reflux disease in patients with duodenal ulcers or reflux oesophagitis.
    Raghunath AS, Hungin AP, Wooff D, Childs S.
    Aliment Pharmacol Ther; 2004 Oct 01; 20(7):733-44. PubMed ID: 15379833
    [Abstract] [Full Text] [Related]

  • 40. Features of chronic inflammation at the gastric cardia and the relationship with Helicobacter pylori infection and oesophagitis.
    Ayhan S, Demir MA, Kandiloglu AR, Saruc M, Kucukmetin N.
    Acta Gastroenterol Belg; 2003 Oct 01; 66(2):144-9. PubMed ID: 12891923
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.